LivaNova (LIVN) Gross Profit Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 11.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.87% |
| Dec 31, 2025 | 9.32% |
| Sep 30, 2025 | 12.73% |
| Jun 30, 2025 | 9.04% |
| Mar 31, 2025 | 8.69% |
| Dec 31, 2024 | 2.06% |
| Sep 30, 2024 | 9.43% |
| Jun 30, 2024 | 7.64% |
| Mar 31, 2024 | 7.54% |
| Dec 31, 2023 | 1.54% |
| Sep 30, 2023 | 10.99% |
| Jun 30, 2023 | 21.30% |
| Mar 31, 2023 | 1.74% |
| Dec 31, 2022 | 2.08% |
| Sep 30, 2022 | -2.16% |
| Jun 30, 2022 | -3.04% |
| Mar 31, 2022 | 0.38% |
| Dec 31, 2021 | -0.80% |
| Sep 30, 2021 | -1.10% |
| Jun 30, 2021 | -3.87% |
| Mar 31, 2021 | 0.27% |
| Dec 31, 2020 | -1.01% |
| Sep 30, 2020 | -3.03% |
| Jun 30, 2020 | -12.24% |
| Mar 31, 2020 | 3.84% |
| Dec 31, 2019 | 11.22% |
| Sep 30, 2019 | 5.84% |
| Jun 30, 2019 | 10.85% |
| Mar 31, 2019 | 8.13% |
| Dec 31, 2017 | 74.18% |